Dehydrotumulosic acid is a triterpene that has been found in P. cocos and has anticancer and anti-inflammatory activities. It enhances the cytotoxicity of vincristine (Item No. 11764) against multidrug-resistant KBv200 cells when used at concentrations of 12.5 or 25 µg/ml. Dehydrotumulosic acid (50 mg/kg) reduces serotonin-induced hind paw edema, as well as ear edema induced by phorbol 12-myristate 13-acetate (TPA; Item No. 10008014), in mice.
Dehydrotumulosic acid is a triterpene that has been found in P. cocos and has anticancer and anti-inflammatory activities. It enhances the cytotoxicity of vincristine (Item No. 11764) against multidrug-resistant KBv200 cells when used at concentrations of 12.5 or 25 µg/ml. Dehydrotumulosic acid (50 mg/kg) reduces serotonin-induced hind paw edema, as well as ear edema induced by phorbol 12-myristate 13-acetate (TPA; Item No. 10008014), in mice.
Shipping & Handling
Shipped In
Room Temperature in continental US; may vary elsewhere
Safety & Storage
Storage Temperature
-20°C
Safety Statement
WARNING This product is not for human or veterinary use. Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Room Temperature in continental US; may vary elsewhere
Safety & Storage
Storage Temperature
-20°C
Safety Statement
WARNING This product is not for human or veterinary use. Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Regulatory & Compliance
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.
We’re currently in BETA - Interested in joining? Let us know and we’ll get you set up with early access.